Lyne Lavoie
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Journal: Menopause (New York, N.Y.)
Published: October 26, 2018
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Journal: Menopause (New York, N.Y.)
Published: January 06, 2016
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
Journal: The Journal of steroid biochemistry and molecular biology
Published: December 10, 2015
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: December 05, 2015
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.
Journal: The journal of sexual medicine
Published: November 25, 2015
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner.
Journal: Climacteric : the journal of the International Menopause Society
Published: October 31, 2015
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.
Journal: Hormone molecular biology and clinical investigation
Published: September 22, 2015
Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
Journal: Hormone molecular biology and clinical investigation
Published: July 31, 2015
Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
Journal: The Journal of steroid biochemistry and molecular biology
Published: June 30, 2015
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone).
Journal: Menopause (New York, N.Y.)
Published: March 04, 2015
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy.
Journal: Climacteric : the journal of the International Menopause Society
Published: December 17, 2014
Last Updated: 09/26/2026